跳至主要内容
临床试验/NCT05011253
NCT05011253已完成不适用

Electronic Trigger for Microhematuria

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2021年10月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,000
试验地点
1
主要终点
Evaluation rate

研究概览

简要总结

The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders.

详细描述

The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders. The message will notify users that a patient has clinically significant microscopic hematuria and is at high risk for underlying malignancy and will include the official recommendations (imaging with a CT urogram, urology evaluation with cystoscopy).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Double (Participant, Investigator)

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 35 years of age or older
  • 3+ RBC on Urinalysis
  • Urinalysis sent during an outpatient encounter
  • any of the following: 60 years of age or older; RBC > 25; current or prior tobacco use; Gross Hematuria

排除标准

  • Under 35 years of age
  • Cystoscopy within 1 year prior to Urinalysis
  • Nitrite positive AND Leukocyte Esterase positive
  • Nitrite positive AND >100 WBC
  • Leukocyte Esterase positive AND >100 WBC
  • Know GU cancer diagnosis
  • Urinalysis ordered by urology provider

结局指标

主要结局

Evaluation rate

时间窗: 180 days of alert

Urology evaluation with cystoscopy and appropriate imaging

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验